Neurologia
Prevenção de demência: quais são as evidências?
24 Mai, 2022 | 11:37hPreventing dementia: what’s the evidence? – Evidently Cochrane
Medicamentos para agitação em pessoas com demência: benefícios e riscos.
24 Mai, 2022 | 11:36hDrugs for agitation in people with dementia: benefits and risks – Evidently Cochrane
Estudo original: Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia – Cochrane Library
Comentário no Twitter (fio – clique para saber mais)
New blog for #DementiaActionWeek: https://t.co/UT1sdwNZRv @CharSquires & @jamie_garr look at the @CochraneDCIG evidence on drugs used to treat agitation & psychosis in people with #dementia & reflect on what doctors & families may want to consider when making treatment decisions pic.twitter.com/Ei7njr3ynL
— Cochrane UK (@CochraneUK) May 20, 2022
Diretriz científica AHA | Prevenção e manejo de quedas em adultos com doença cardiovascular.
23 Mai, 2022 | 13:40hComunicado de imprensa: Statement addresses ways to prevent heart-related risks for falling – American Heart Association
Comentário: AHA News: Falls Can Be a Serious, Poorly Understood Threat to People With Heart Disease – HealthDay
Diretrizes SCAI para tratamento do forame oval patente.
23 Mai, 2022 | 13:28hSCAI Guidelines for the Management of Patent Foramen Ovale – JSCAI
Editorial: New SCAI Guidelines: Trying to Close the Holes in the PFO Literature – JSCAI
Comentário: PFO Closure Guidelines Address Older Adults, Trial-Excluded Groups— Document acknowledges skimpy evidence – MedPage Today (free registration required)
Conteúdos relacionados:
Advances in the management of cardioembolic stroke associated with patent foramen ovale – The BMJ
Heterogeneity of Treatment Effects in an Analysis of Pooled Individual Patient Data From Randomized Trials of Device Closure of Patent Foramen Ovale After Stroke – JAMA (link para o resumo – $ para o texto completo)
M-A | Comparação da amitriptilina com outros tratamentos aprovados pelo FDA para fibromialgia.
23 Mai, 2022 | 13:21hEstudo randomizado | Tenecteplase vs. alteplase para tratamento de AVC isquêmico agudo.
23 Mai, 2022 | 13:17hTenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial – The Lancet Neurology (link para o resumo – $ para o texto completo)
Revisão sistemática | Disfagia pós-AVC: prognóstico e tratamento.
23 Mai, 2022 | 13:09hRevisão sistemática | Angioplastia transluminal percutânea e colocação de stent para estenose arterial vertebral.
23 Mai, 2022 | 13:06hPercutaneous transluminal angioplasty and stenting for vertebral artery stenosis – Cochrane Library
Resumo: Endovascular treatment for vertebral artery stenosis – Cochrane Library
Descoberta revela que bloquear a inflamação pode levar à dor crônica.
20 Mai, 2022 | 14:09hComunicado de imprensa: Discovery reveals blocking inflammation may lead to chronic pain – McGill University
Estudo original: Acute inflammatory response via neutrophil activation protects against the development of chronic pain – Science Translational Medicine
Comentário no Twitter
Challenging medical dogma:
A very important new report suggests that non-steroidal inflammatory medications for acute pain can lead to chronic painhttps://t.co/Z8yjFFBCkK @ScienceTM https://t.co/YGjkXbvNTa pic.twitter.com/f4xVezAhau— Eric Topol (@EricTopol) May 18, 2022